Synflorix licence extended for use in children up to 5 years old

The deltoid muscle of the upper arm in young children and the anterolateral thigh in infants are the preferred sites of injection | SCIENCE PHOTO LIBRARY
The deltoid muscle of the upper arm in young children and the anterolateral thigh in infants are the preferred sites of injection | SCIENCE PHOTO LIBRARY

Synflorix (pneumococcal vaccine) can now be prescribed for use in children from 2–5 years of age.

The recommended vaccination schedule consists of 2 doses of 0.5ml with a minimum interval of 2 months between doses. It is recommended that children who receive a first dose of Synflorix should complete the full vaccination course with Synflorix. A 6-month booster dose should be given according to the dose regimen that is appropriate to their age at the time of commencing the vaccination series.

This licence extension now means that the vaccine can be given to children from 6 weeks up to 5 years of age.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases